CICLESONIDE
| Brand name | OMNARIS |
|---|---|
| Active ingredient | CICLESONIDE |
| Strength | 0.05MG/SPRAY |
| Dosage form | SPRAY, METERED |
| Route | NASAL |
| Modality | Small molecule |
| FDA approval | October 2006 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8371292 | February 2028 | use U-1356 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.